REGN - REGENERON PHARMACEUTICALS, INC.
766.66
-24.150 -3.150%
Share volume: 636,991
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$790.81
-24.15
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 10-31-2024 | 02-05-2025 | 04-29-2025 | 08-01-2025 | 10-28-2025 | 02-04-2026 | |
| Assets | |||||||||
| Total Assets | 34.370 B | 36.087 B | 37.442 B | 37.759 B | 37.545 B | 38.219 B | 40.169 B | 40.559 B | |
| Current Assets | 18.872 B | 19.082 B | 19.334 B | 18.661 B | 17.572 B | 16.860 B | 17.981 B | 18.022 B | |
| Inventories | 2.715 B | 2.874 B | 3.018 B | 3.087 B | 3.192 B | 3.206 B | 3.254 B | 3.201 B | |
| Other Current Assets | 414.900 M | 681.900 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 414.900 M | 681.900 M | 7.785 B | 6.524 B | 5.259 B | 5.474 B | 5.937 B | 5.487 B | |
| Total Receivables | 5.222 B | 5.717 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 10.520 B | 9.809 B | 2.012 B | 2.488 B | 3.090 B | 1.996 B | 2.506 B | 3.118 B | |
| Total Non-current Assets | 15.498 B | 17.005 B | 8.491 B | 8.900 B | 9.276 B | 10.058 B | 10.286 B | 10.261 B | |
| Property Plant Equipment | 4.226 B | 4.306 B | 4.439 B | 4.600 B | 4.694 B | 4.841 B | 5.002 B | 5.120 B | |
| Other Assets | 470.200 M | 993.800 M | 13.669 B | 14.499 B | 15.279 B | 16.519 B | 17.186 B | 17.416 B | |
| Intangible Assets | 1.059 B | 1.102 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 34.370 B | 36.087 B | 37.442 B | 37.759 B | 37.545 B | 38.219 B | 40.169 B | 40.559 B | |
| Total liabilities | 7.379 B | 7.881 B | 8.116 B | 8.406 B | 8.158 B | 8.280 B | 9.212 B | 9.302 B | |
| Total current liabilities | 3.581 B | 3.509 B | 3.661 B | 3.944 B | 3.567 B | 3.667 B | 4.425 B | 4.368 B | |
| Accounts Payable | 671.300 M | 561.700 M | 497.300 M | 789.500 M | 705.500 M | 723.900 M | 903.800 M | 939.000 M | |
| Other liabilities | 1.094 B | 1.669 B | 1.544 B | 1.571 B | 1.674 B | 1.702 B | 1.862 B | 2.019 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 2.703 B | 2.704 B | 1.984 B | 1.984 B | 1.985 B | 1.985 B | 1.986 B | 1.986 B | |
| Other liabilities | 1.094 B | 1.669 B | 1.544 B | 1.571 B | 1.674 B | 1.702 B | 1.862 B | 2.019 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 26.991 B | 28.206 B | 29.326 B | 29.354 B | 29.388 B | 29.939 B | 30.958 B | 31.257 B | |
| Common stock | 107.800 M | 108.100 M | 12.703 B | 12.856 B | 13.192 B | 13.491 B | 13.787 B | 13.995 B | |
| Retained earnings | 27.982 B | 29.415 B | 30.755 B | 31.673 B | 32.384 B | 33.680 B | 35.046 B | 35.797 B |